Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. DOCS
DOCS logo

DOCS Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
24.500
Open
23.500
VWAP
23.98
Vol
3.70M
Mkt Cap
4.51B
Low
23.050
Amount
88.80M
EV/EBITDA(TTM)
15.07
Total Shares
184.71M
EV
3.83B
EV/OCF(TTM)
12.14
P/S(TTM)
7.79
Doximity, Inc. provides a digital platform for the United States medical professionals. It offers marketing, hiring, and workflow solutions to pharmaceutical manufacturers, health systems, medical recruiting firms, and other healthcare companies. Its marketing solutions enable its pharmaceutical and health system customers to get the right content, services, and peer connections to the right medical professionals through a variety of modules. Its hiring solutions provide digital recruiting capabilities to health systems and medical recruiting firms, enabling them to identify, connect with, and hire from its network of both active and passive medical professional candidates, who might otherwise be missed through traditional recruiting channels. Its workflow solutions include its telehealth, on-call scheduling, and AI-powered workflow tools, are designed to help clinicians streamline their clinical workflow, reduce their administrative burden, and connect with patients and colleagues.
Show More

Events Timeline

(ET)
2026-04-20
09:00:00
U.S. Stock Futures Decline Amid Rising Tensions with Iran
select
2026-04-17 (ET)
2026-04-17
17:00:00
Doximity CFO Anna Bryson Resigns, Siddharth Sitaram Appointed Interim CFO
select

News

moomoo
4.0
04-20moomoo
DOXIMITY INC: TRUIST SECURITIES LOWERS RATING TO HOLD FROM BUY; REDUCES TARGET PRICE TO $29 FROM $37
  • Company Overview: Doximity, a healthcare technology company, has made significant changes to its financial outlook.

  • Target Price Adjustment: The company has cut its target price from $37 to $29, reflecting a more conservative market expectation.

seekingalpha
5.0
04-18seekingalpha
Doximity CFO Anna Bryson Resigns Amid Transition
  • Executive Departure: Doximity accepted the resignation of CFO Anna Bryson on April 13, 2026, following her medical leave, indicating potential challenges in executive stability that may affect investor confidence.
  • Interim Financial Leadership: Since February 3, 2026, Chief Accounting Officer Siddharth Sitaram has been serving as the interim principal financial and accounting officer until a new CFO is appointed, which could lead to delays in financial decision-making and impact strategic execution.
  • Guidance Reaffirmation: Doximity reaffirmed its previously issued guidance for Q4 and the full fiscal year ending March 31, 2026, demonstrating the company's intent to maintain stable financial expectations amid uncertain market conditions, aiming to bolster investor confidence.
  • Uncertain Growth Outlook: Despite the reaffirmation of guidance, the market outlook for Doximity remains murky, which could affect its stock performance, prompting investors to closely monitor the upcoming CFO appointment and its implications for the company's strategy.
Yahoo Finance
2.0
04-09Yahoo Finance
Market Volatility Following Anthropic's Managed Agents Announcement
  • AI Disruption: Anthropic's announcement of Managed Agents has sparked investor concerns about potential disruptions to existing SaaS business models, leading to notable declines in stocks such as Doximity, Guidewire, and Intuit, which fell by 3%, 5%, and 5%, respectively.
  • Overreaction in Market: Despite the severe market reaction to AI agents, analysts suggest that significant price drops may present buying opportunities for high-quality stocks, particularly as investors look for long-term value amidst volatility.
  • Health Catalyst Volatility: Health Catalyst has experienced 51 moves greater than 5% over the past year, with its current share price at $1.03, representing a 77.3% decline from its 52-week high of $4.52, indicating cautious market sentiment regarding its future prospects.
  • Geopolitical Tensions: Recent geopolitical tensions have escalated, pushing oil prices to new highs, which could increase business costs and trigger inflation, further impacting global economic growth, necessitating investor vigilance on related developments.
Yahoo Finance
9.5
04-08Yahoo Finance
Doximity Reports Weak Earnings, Stock Down 31.2%
  • Earnings Beat: Doximity reported revenues of $185.1 million, a 9.8% year-over-year increase, exceeding analyst expectations by 2%, yet the revenue and EBITDA guidance for the next quarter fell short, leading to negative market sentiment.
  • Significant Stock Decline: Following the earnings report, Doximity's stock plummeted by 31.2%, currently trading at $22.93, indicating investor concerns regarding future growth prospects.
  • Industry Performance Comparison: Within the vertical software sector, Doximity's performance was notably weak, as the overall industry reported a 2.5% revenue beat in Q4, highlighting Doximity's struggle to keep pace with sector growth.
  • Shifting Market Sentiment: Amid rising geopolitical risks, investor confidence in the software sector has waned, and Doximity's earnings report failed to alleviate concerns about its future profitability.
moomoo
4.0
04-08moomoo
DOXIMITY INC: EVERCORE ISI Downgrades to In Line from Outperform; Lowers Target Price to $25 from $30
  • Company Overview: Doximity, a healthcare technology company, has made significant changes to its financial outlook.

  • Financial Adjustments: The company has cut its target price from $30 to $25, indicating a shift in market expectations.

Yahoo Finance
6.5
04-03Yahoo Finance
Profitable Companies May Not Last
  • Caution on GE Healthcare: GE Healthcare's annual revenue growth of only 2.7% over the past two years significantly lags behind other healthcare firms, indicating core business struggles that may necessitate acquisitions for growth stimulation, with a current share price of $70.42 and a forward P/E of 14.2x.
  • Northern Trust's Slow Growth: Northern Trust has experienced muted annual revenue growth of 5.8% over the last five years, with its EPS growth of 9.3% falling short of peer averages, trading at $142.24 per share and a forward P/E of 13x, reflecting demand lagging behind financial performance.
  • Doximity's Strong Performance: Doximity boasts an impressive annual revenue growth of 29.3% over the past five years, showcasing market share gains, and its user-friendly software allows clients to quickly ramp up spending, with a current stock price of $22.94 and a forward price-to-sales ratio of 6.7x, indicating robust cash flow and investment flexibility.
  • High-Quality Stocks in Focus: While many profitable companies exist, not all are poised for sustained growth; analysis reveals that only a select few can maintain high-quality growth across various market conditions, prompting investors to focus on these potential winners.
Wall Street analysts forecast DOCS stock price to rise
18 Analyst Rating
Wall Street analysts forecast DOCS stock price to rise
14 Buy
4 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
25.00
Averages
42.75
High
63.00
Current: 0.000
sliders
Low
25.00
Averages
42.75
High
63.00
Truist
Buy
to
Hold
downgrade
$37 -> $29
AI Analysis
2026-04-20
New
Reason
Truist
Price Target
$37 -> $29
AI Analysis
2026-04-20
New
downgrade
Buy
to
Hold
Reason
Truist downgraded Doximity to Hold from Buy with a price target of $29, down from $37. The firm has a taken a more cautious outlook on Doximity, saying its revenue growth visibility has softened and structural risks are mounting. There is limited clarity on pharma digital marketing budgets, the analyst tells investors in a research note. Truist believes Doximity's fiscal 2027 growth profile will likely be below consensus while it faces emerging competitive pressure from AI-native platforms such as OpenEvidence.
Truist
Buy
to
Hold
downgrade
$29
2026-04-19
New
Reason
Truist
Price Target
$29
2026-04-19
New
downgrade
Buy
to
Hold
Reason
Truist downgraded Doximity to Hold from Buy with a $29 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for DOCS
Unlock Now

Valuation Metrics

The current forward P/E ratio for Doximity Inc (DOCS.N) is 15.34, compared to its 5-year average forward P/E of 56.64. For a more detailed relative valuation and DCF analysis to assess Doximity Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
56.64
Current PE
15.34
Overvalued PE
101.84
Undervalued PE
11.44

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
36.31
Current EV/EBITDA
15.85
Overvalued EV/EBITDA
64.90
Undervalued EV/EBITDA
7.73

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
16.85
Current PS
6.54
Overvalued PS
26.00
Undervalued PS
7.70

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

list high market cap first
Intellectia · 25 candidates
Sector: Financial Technology (Fintech) & Infrastructure, Software & IT Services, Technology, Technology EquipmentMarket Cap Category: mega, large, midList Exchange: XNYS, XNAS, XASEYear Price Change Pct: <= $-40.00
Ticker
Name
Market Cap$
top bottom
MSTR logo
MSTR
Strategy Inc
49.61B
CPRT logo
CPRT
Copart Inc
32.14B
WDAY logo
WDAY
Workday Inc
31.90B
FICO logo
FICO
Fair Isaac Corp
24.45B
TEAM logo
TEAM
Atlassian Corp
17.41B
CSGP logo
CSGP
Costar Group Inc
16.50B
current bullish rsi divergences
Intellectia · 213 candidates
Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
NVO logo
NVO
Novo Nordisk A/S
170.38B
MELI logo
MELI
MercadoLibre Inc
89.62B
NTES logo
NTES
NetEase Inc
73.21B
ET logo
ET
Energy Transfer LP
63.96B
BIDU logo
BIDU
Baidu Inc
45.60B
TCOM logo
TCOM
Trip.com Group Ltd
35.00B
best stocks to short now
Intellectia · 7 candidates
Market Cap: >= 1000.00MRegion: USPrice: $3.00 - $250.00Analyst Consensus: Moderate Buy, Hold, Moderate Sell, Strong SellQuarter Eps Yoy Growth: <= 0.0%Pe Ttm: >= 30List Exchange: XNYS, XNAS, XASEPs Ratio: >= 6.00Quarter Price Change Pct: <= $-8.00Monthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
CSGP logo
CSGP
CoStar Group Inc
19.08B
EW logo
EW
Edwards Lifesciences Corp
44.36B
LEU logo
LEU
Centrus Energy Corp
3.64B
SOFI logo
SOFI
SoFi Technologies Inc
24.52B
SHOP logo
SHOP
Shopify Inc
144.31B
DOCS logo
DOCS
Doximity Inc
4.56B
biggest loser in stock market this week
Intellectia · 18 candidates
Market Cap: >= 300.00MList Exchange: XNYS, XNAS, XASEWeek Price Change Pct: <= $-20.00Monthly Average Dollar Volume: >= 200,000
Ticker
Name
Market Cap$
top bottom
KD logo
KD
Kyndryl Holdings Inc
2.54B
FLNC logo
FLNC
Fluence Energy Inc
3.49B
MOH logo
MOH
Molina Healthcare Inc
6.40B
HIMS logo
HIMS
Hims & Hers Health Inc
3.92B
MNDY logo
MNDY
monday.com Ltd
3.82B
PI logo
PI
Impinj Inc
3.34B
10 top oversold stocks
Intellectia · 58 candidates
Market Cap: >= 5.00BRegion: USPrice: >= $5.00Rsi Category: oversoldList Exchange: XNYS, XNAS, XASEMonth Price Change Pct: <= $-20.00Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
U logo
U
Unity Software Inc
10.01B
RDDT logo
RDDT
Reddit Inc
27.07B
HUBS logo
HUBS
HubSpot Inc
12.12B
APP logo
APP
Applovin Corp
137.11B
IT logo
IT
Gartner Inc
11.15B
DOCS logo
DOCS
Doximity Inc
5.06B
Growth stocks to invest in
Intellectia · 24 candidates
Market Cap: >= 5.00BRegion: USQuarter Revenue Yoy Growth: >= 20.0%Market Cap Category: large, midRevenue 5yr Cagr: >= 15Eps 5yr Cagr: >= 15List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
CELH logo
CELH
Celsius Holdings Inc
13.94B
FUTU logo
FUTU
Futu Holdings Ltd
22.82B
DOCS logo
DOCS
Doximity Inc
7.33B
ATAT logo
ATAT
Atour Lifestyle Holdings Ltd
5.01B
AXON logo
AXON
Axon Enterprise Inc
45.20B
GMAB logo
GMAB
Genmab A/S
20.27B
What stock has the most upside this 2026?
Intellectia · 48 candidates
Market Cap: 1000.00M - 100.00BAnalyst Consensus: Strong Buy, Moderate BuyRevenue 5yr Cagr: >= 10Eps 5yr Cagr: >= 10List Exchange: XNYS, XNAS, XASETarget Price Upside Potential: MoreAbovePrice
Ticker
Name
Market Cap$
top bottom
KSPI logo
KSPI
Kaspi.kz AO
15.02B
QFIN logo
QFIN
Qfin Holdings Inc
2.14B
NICE logo
NICE
Nice Ltd
7.07B
PTC logo
PTC
PTC Inc
19.28B
JD logo
JD
JD.com Inc
42.34B
TW logo
TW
Tradeweb Markets Inc
24.31B
best stocks to invest in 2026 q1
Intellectia · 21 candidates
Market Cap: >= 5.00BMarket Cap Category: large, midAnalyst Consensus: Strong Buy, Moderate BuyReturn On Equity: >= 12.0%Target Price Upside Potential: MoreAbovePriceOne Month Predict Return: >= 5.0%
Ticker
Name
Market Cap$
top bottom
MORN logo
MORN
Morningstar Inc
8.63B
KSPI logo
KSPI
Kaspi.kz AO
14.51B
MANH logo
MANH
Manhattan Associates Inc
10.01B
LOGI logo
LOGI
Logitech International SA
13.49B
TTD logo
TTD
Trade Desk Inc
17.09B
PDD logo
PDD
PDD Holdings Inc
150.37B
list 4 promising quantum computing stocks
Intellectia · 294 candidates
Market Cap: >= 500.00MBeta: LowRisk, ModerateRiskRevenue 5yr Cagr: >= 10Eps 5yr Cagr: >= 0
Ticker
Name
Market Cap$
top bottom
LBRDA logo
LBRDA
Liberty Broadband Corp
6.25B
FRHC logo
FRHC
Freedom Holding Corp
7.61B
CIVI logo
CIVI
Civitas Resources Inc
2.32B
DLO logo
DLO
Dlocal Ltd
3.98B
OWL logo
OWL
Blue Owl Capital Inc
24.58B
CCB logo
CCB
Coastal Financial Corp (EVERETT)
1.73B
what about health tech stocks and robots?
Intellectia · 18 candidates
Market Cap: 50.00M - 50.00BWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
ROK logo
ROK
Rockwell Automation Inc
47.26B
SYM logo
SYM
Symbotic Inc
36.98B
TER logo
TER
Teradyne Inc
36.32B
VEEV logo
VEEV
Veeva Systems Inc
36.12B
ZBRA logo
ZBRA
Zebra Technologies Corp
12.31B
DOCS logo
DOCS
Doximity Inc
7.50B

Whales Holding DOCS

R
Rice Hall James & Associates, LLC
Holding
DOCS
+10.32%
3M Return
W
William Blair Investment Management, LLC
Holding
DOCS
+5.57%
3M Return
T
The Bryn Mawr Trust Company
Holding
DOCS
+5.03%
3M Return
E
E. Öhman J:or Wealth Management
Holding
DOCS
+3.62%
3M Return
I
Integral Health Asset Management, LLC
Holding
DOCS
+2.91%
3M Return
C
Carmignac Gestion SA
Holding
DOCS
+2.60%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Doximity Inc (DOCS) stock price today?

The current price of DOCS is 24.39 USD — it has decreased -1.3

What is Doximity Inc (DOCS)'s business?

Doximity, Inc. provides a digital platform for the United States medical professionals. It offers marketing, hiring, and workflow solutions to pharmaceutical manufacturers, health systems, medical recruiting firms, and other healthcare companies. Its marketing solutions enable its pharmaceutical and health system customers to get the right content, services, and peer connections to the right medical professionals through a variety of modules. Its hiring solutions provide digital recruiting capabilities to health systems and medical recruiting firms, enabling them to identify, connect with, and hire from its network of both active and passive medical professional candidates, who might otherwise be missed through traditional recruiting channels. Its workflow solutions include its telehealth, on-call scheduling, and AI-powered workflow tools, are designed to help clinicians streamline their clinical workflow, reduce their administrative burden, and connect with patients and colleagues.

What is the price predicton of DOCS Stock?

Wall Street analysts forecast DOCS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DOCS is42.75 USD with a low forecast of 25.00 USD and a high forecast of 63.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Doximity Inc (DOCS)'s revenue for the last quarter?

Doximity Inc revenue for the last quarter amounts to 185.05M USD, increased 9.76

What is Doximity Inc (DOCS)'s earnings per share (EPS) for the last quarter?

Doximity Inc. EPS for the last quarter amounts to 0.31 USD, decreased -16.22

How many employees does Doximity Inc (DOCS). have?

Doximity Inc (DOCS) has 830 emplpoyees as of April 21 2026.

What is Doximity Inc (DOCS) market cap?

Today DOCS has the market capitalization of 4.51B USD.